Company

About UroMems

UroMems was founded in 2011 and focuses on designing, developing and commercializing active implantable medical devices.

The company is based at the heart of the French Alps, in the city of Grenoble, representing one of the most dynamic French area in the Medtechs industry.

UroMems is highly innovative and focuses on clearly identified clinical unmet needs, not only for their prevalence but also for their negative impact on patient’s quality of life.

Since the inception of the company, significant investments have been made for the development of the UroMems’ first product. This includes a € 12 million series A financing round led by Wellington Partners, Munich, Germany, Bpifrance via FABS Fund, Cita Investissement, Supernova Invest and b-to-v Partners AG.

Our mission

UroMems’s mission is to offer implantable solutions that are:

  • Easy to use for the patients
  • Easy to operate for healthcare professionals
  • More effective, more reliable and less invasive than current surgical techniques

In a particularly demanding economic and regulatory context, the company’s ambition is to improve current surgical treatments for helping as many patients as possible, particularly by reducing associated side effects.

In order to fullfil this ambition, UroMems evolves in a leading-edge technology environment and has established partnerships with internationally renowned experts, research laboratories and industrial partners.

Led by the founders’ vision, UroMems follows the strictest ethics.

Board of Directors

HamidLamraoui
Hamid
Lamraoui
CEO
& co-founder
StéphaneLavallée
Stéphane
Lavallée
BD director
& co-founder
RainerStrohmenger
Rainer
Strohmenger
General Partner
Wellington partners
Marie-LaureGarrigues
Marie-Laure
Garrigues
Investment director
Bpifrance
PierreMozer
Pierre
Mozer
Clinical director
& co-founder
AlainRipart
Alain
Ripart
Strategic advisor
ChristianJung
Christian
Jung
Principal
Wellington partners
CeliaHart
Celia
Hart
Investment director
Supernova Invest